Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
DSIP is under active research for potential application in: Individuals with insomnia or light, fragmented sleep Those with chronic stress or HPA axis dysfunction Athletes and biohackers seeking enhanced recovery People working night shifts or experiencing circadian misalignment Adults with low growth hormone output or reduced sleep efficiency Patients with PTSD or trauma-related sleep disruption (research ongoing) DSIP is not FDA-approved for any medical condition and should only be used in research settings under supervision
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
31 (Suppl 3), S117S135 (2012)
Your skin might temporarily lose some of its structural support
Thus, G6PD-d may modulate immune functions by limiting rapid lymphocyte proliferation and differentiation that are key components of adaptive immunity
10.1158/1078-0432.ccr-14-1200
US$ 27.34
US$ 27.49
US$ 26.40
US$ 20.21
US$ 21.18
US$ 26.38
US$ 26.25
US$ 22.69
US$ 24.87
US$ 28.52
US$ 25.61